Department of Renal and Body Fluid Physiology, M. Mossakowski Medical Research Centre, Polish Academy of Sciences, Warsaw, Poland.
Department of Experimental and Clinical Neuropathology, M. Mossakowski Medical Research Centre, Polish Academy of Sciences, Warsaw, Poland.
J Physiol Pharmacol. 2019 Apr;70(2). doi: 10.26402/jpp.2019.2.05. Epub 2019 Jul 22.
High salt (HS) intake can lead to hypertension, probably the result of the predominance of vasoconstrictor reactive oxygen species over vasodilator nitric oxide (NO). We aimed to examine if the supposed NO deficiency and the resultant blood pressure increase could be corrected by supplementation of L-arginine, the substrate, and tetrahydrobiopterin (BH), a co-factor of NO synthases. Wistar rats without known genetic background of salt sensitivity were exposed to HS diet (4%Na) for 10 or 26 days, without or with supplementation with oral L-arginine, 1.4 mg/kg b.w. daily, alone or together with intraperitoneal BH, 10 mg/kg daily. Systolic blood pressure (SBP, tail-cuff method) was measured repeatedly and found to increase ~40 mmHg after 26 days; L-arginine and BH did not significantly attenuate this increase. At the end of chronic studies, in anaesthetized rats the diet- and treatment-induced changes in renal haemodynamics were assessed. HS diet selectively decreased (-30%, P < 0.03) the inner medullary blood flow (IMBF, laser-Doppler flux) without changing total or cortical renal perfusion. Arginine supplementation tended to raise all renal circulatory parameters, and distinctly increased IMBF, to 61% above the HS diet level (P < 0.05). In conclusion, unlike in confirmed genetically determined salt-dependent hypertension, L-arginine and BH supplementation failed to attenuate the SBP increase observed after exposure to HS diet. On the other hand, arginine increased total and regional renal perfusion, especially IMBF. This suggests that the delivery of arginine increased intrarenal NO synthesis, an action of renoprotective potential which presumably countered the harmful influence of the local tissue oxidative stress.
高盐(HS)摄入可导致高血压,可能是由于血管收缩性活性氧物质超过血管扩张性一氧化氮(NO)所致。我们旨在研究假设的 NO 缺乏症和由此导致的血压升高是否可以通过补充 L-精氨酸(NO 合酶的底物)和四氢生物蝶呤(BH,NO 合酶的辅助因子)来纠正。没有已知的盐敏感性遗传背景的 Wistar 大鼠暴露于高盐饮食(4%Na)中 10 或 26 天,不补充或补充口服 L-精氨酸,1.4mg/kg.b.w.每天,单独或与腹腔内 BH 一起,每天 10mg/kg。通过尾套法多次测量收缩压(SBP),发现 26 天后增加了约 40mmHg;L-精氨酸和 BH 并未显著减弱这种增加。在慢性研究结束时,在麻醉大鼠中评估了饮食和治疗引起的肾血液动力学变化。高盐饮食选择性地降低了(-30%,P < 0.03)内髓质血流(激光多普勒流量),而不改变总肾或皮质灌注。精氨酸补充剂倾向于提高所有肾循环参数,并明显增加内髓质血流,比高盐饮食水平高出 61%(P < 0.05)。总之,与已确认的遗传决定的盐依赖性高血压不同,L-精氨酸和 BH 补充未能减弱暴露于高盐饮食后观察到的 SBP 升高。另一方面,精氨酸增加了总肾和区域肾灌注,尤其是内髓质血流。这表明精氨酸的输送增加了肾内 NO 合成,这种作用具有潜在的肾保护作用,可能抵消了局部组织氧化应激的有害影响。